Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma

BACKGROUND: Oxaliplatin-based chemotherapy is widely used to treat hepatocellular carcinoma (HCC). Recent studies suggested that therapeutic resistance of tumors was affected by tumor microenvironment (TME). As a major component of TME, the role of tumor-associated macrophages (TAMs) on drug resista...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Cell Int
Autors principals: Fu, Xiu-Tao, Song, Kang, Zhou, Jian, Shi, Ying-Hong, Liu, Wei-Ren, Shi, Guo-Ming, Gao, Qiang, Wang, Xiao-Ying, Ding, Zhen-Bin, Fan, Jia
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434873/
https://ncbi.nlm.nih.gov/pubmed/30962765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0771-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars